Pharmacogenetic testing, which is used to classify how patients with major depressive disorder (MDD) metabolize medications, reduces adverse drug-gene interactions, new research shows. In a randomized ...
Myriad Genetics, Inc. announced that a study published in the Journal of Clinical Psychopharmacology found that the GeneSight® Psychotropic Test significantly reduced psychiatric hospitalizations in ...
Patients with asthma and major depressive disorder had more negative beliefs about their asthma, worse treatment adherence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results